Population pharmacokinetic pharmacodynamic modeling of istradefylline in patients with Parkinson's disease.

被引：0
|
作者：
Knebel, W.
Rao, N.
Bergsma, T.
Gastonguay, M.
Mori, A.
Uchimura, T.
Allenby, K.
Dvorchik, B.
Sussman, N.
Chaikin, P.
机构：
来源：
JOURNAL OF CLINICAL PHARMACOLOGY | 2007年 / 47卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
12
引用
收藏
页码：1185 / 1185
页数：1
相关论文
共 50 条
  • [1] Population Pharmacokinetic-Pharmacodynamic Analysis of Istradefylline in Patients With Parkinson Disease
    Knebel, William
    Rao, Niranjan
    Uchimura, T.
    Mori, Akihisa
    Fisher, Jeannine
    Gastonguay, Marc R.
    Chaikin, Philip
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 52 (10): : 1468 - 1481
  • [2] Population pharmacokinetic and pharmacokinetic/pharmacodynamic modeling of istradefylline
    Rao, Niranjan
    Knebel, William
    Gastonguay, Marc
    Uchimura, Tatsuo
    Bergsma, Tim
    Mori, Akihisa
    [J]. NEUROLOGY, 2008, 70 (11) : A60 - A60
  • [3] Population Pharmacokinetic Analysis of Istradefylline in Healthy Subjects and in Patients With Parkinson's Disease
    Knebel, William
    Rao, Niranjan
    Uchimura, Tatsuo
    Mori, Akihisa
    Fisher, Jeannine
    Gastonguay, Marc R.
    Chaikin, Philip
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 51 (01): : 40 - 52
  • [4] POPULATION PHARMACOKINETIC-PHARMACODYNAMIC MODELING OF THE EFFECTS OF APLINDORE IN PATIENTS WITH EARLY PARKINSON'S DISEASE
    Liu, Yong
    Sprenger, Ken
    Stankovic, Serge
    Cioffi, Carolyn
    Anciro, Lynn
    Rajachandran, Lavanya
    Tschopp, Renee
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 49 (09): : 1101 - 1101
  • [5] Pharmacokinetic-pharmacodynamic modeling of levodopa and metabolites in Parkinson's disease patients
    Marsot, A.
    Micallef, J.
    Azulay, J. P.
    Blin, O.
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2017, 31 : 45 - 45
  • [6] Population pharmacokinetic and pharmacodynamic analyses of safinamide in subjects with Parkinson's disease
    Loprete, Luca
    Leuratti, Chiara
    Cattaneo, Carlo
    Thapar, Mita M.
    Farrell, Colm
    Sardina, Marco
    [J]. PHARMACOLOGY RESEARCH & PERSPECTIVES, 2016, 4 (05):
  • [7] Population pharmacodynamic modeling of levodopa in patients with Parkinson's disease receiving entacapone
    Trocóniz, IF
    Naukkarinen, TH
    Ruottinen, HM
    Rinne, UK
    Gordin, A
    Karlsson, MO
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1998, 64 (01) : 106 - 116
  • [8] Pharmacokinetic-Pharmacodynamic Modeling of Levodopa in Patients With Advanced Parkinson Disease
    Adamiak, Urszula
    Kaldonska, Maria
    Klodowska-Duda, Gabriela
    Wyska, Elzbieta
    Safranow, Krzysztof
    Bialecka, Monika
    Gawronska-Szklarz, Barbara
    [J]. CLINICAL NEUROPHARMACOLOGY, 2010, 33 (03) : 135 - 141
  • [9] Pharmacokinetic-Pharmacodynamic Relationships of Apomorphine in Patients with Parkinson’s Disease
    Cees Neef
    Teus van Laar
    [J]. Clinical Pharmacokinetics, 1999, 37 : 257 - 271
  • [10] Pharmacokinetic-pharmacodynamic relationships of apomorphine in patients with Parkinson's disease
    Neef, C
    van Laar, T
    [J]. CLINICAL PHARMACOKINETICS, 1999, 37 (03) : 257 - 271
12345